Down -19.76% in 4 Weeks, Here's Why NanoX Imaging (NNOX) Looks Ripe for a Turnaround
NanoX Imaging (NNOX) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
Bears are Losing Control Over NanoX Imaging (NNOX), Here's Why It's a 'Buy' Now
NanoX Imaging (NNOX) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.
Is NanoX Imaging (NNOX) Stock Outpacing Its Business Services Peers This Year?
Here is how Nano-X Imaging Ltd. (NNOX) and Deluxe (DLX) have performed compared to their sector so far this year.
Down 53%. Is Nano-X Imaging a Buy on the Dip?
Nano-X Imaging stock rallied in February, but it's still down by about half over the past year. The FDA approved the company's flagship device over a year ago, but sales have been disappointing.
Nano-X Imaging Ltd. (NNOX) Q1 2024 Earnings Call Transcript
Nano-X Imaging Ltd. (NASDAQ:NNOX ) Q1 2024 Earnings Conference Call May 28, 2024 8:30 AM ET Company Participants Mike Cavanaugh - Investor Relations Erez Meltzer - Chief Executive Officer Ran Daniel - Chief Financial Officer Conference Call Participants Ross Osborn - Cantor Fitzgerald Jeff Cohen - Ladenburg Thalmann Operator Good day and thank you for standing by.
